Author:
Gyrylova S N,Ruksha T G,Zobova S N,Komina A V,Aksenenko M B,GYRYLOVA S N,RUKSHA T G,ZOBOVA S N,KOMINA A V,AKSENENKO M B
Abstract
Skin melanoma is an aggressive malignant neoplasm. Mutation of the BRAF gene, BRAF V600E, is observed in more than
70% of melanoma cases. Assessment of the BRAF status in patients suffering from skin melanoma is an important stage
in patient screening for selection of further therapy.
To reveal the mutation of BRAF V600E, 27 histology samples taken from patients with skin melanoma residing in the
Krasnodar territory were examined by means of defining the Restriction Fragment Length Polymorphism (PFLP assay).
Our studies revealed the BRAF V600E mutation in 26 of 27 histology samples of skin melanoma. It was shown that the
mutation is not associated with any sex-related, age-related, clinical and pathological features of the tumor.
Publisher
Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov
Reference10 articles.
1. Losina E., Walensky R.P., Geller A. et al. Visual Screening for Malignant Melanoma.A Cost-effectiveness Analysis. Arch Dermatol 2007; 143: 21-28.
2. Merabishvili V.M. Malignant Melanoma-up-todate tendencies (the morbidity, the mortality, the diagnostics). Oncological issues 2006; 3: 275-87.
3. Пак Д.Д., Белова Е.А., Лазутина Т.Н. Исследование сторожевых лимфатических узлов у больных с меланомой кожи. Росс. онкол. журн. 2008; 4: 22-28.
4. Garbe C., Eigentler T.K. Diagnosis and treatment of cutaneous melanoma: state of the art 2006. Melanoma Research 2007; 17: 117-27.
5. Atkins M.B., Elder D.E., Essner R., et al. Innovations and challenges in melanoma: summary statement from the first Cambridge conference. Clinical Cancer Research 2006; 12: 2291-6s.